ArticleNature communications2015

Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation.

Ping-Xia Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.